logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
K

Ken Herrmann

university of hamburg

94H-index
974Paper Count
3.3WCitation Count
Published Papers 439
Publication Date
logo
[177Lu]Lu-DOTA-TATE plus long-acting octreotide in patients with newly diagnosed, advanced, grade 2–3, gastroenteropancreatic neuroendocrine tumours: preplanned and post-hoc efficacy analyses from the randomised, phase 3 NETTER-2 trial
errEClinicalMedicine
IF10
err2026-08-07
err0
errOAAI
errDiego Ferone; Marianne Pavel; Ken Herrmann; Pamela L. Kunz; Sten Myrehaug; Daniel Halperin; Beth Chasen; Jaume Capdevila; Amparo García-Burillo; Salvatore Tafuto; Secondo Lastoria; Do-Youn Oh; Changhoon Yoo; Stephen Falk; Thorvardur R. Halfdanarson; Maddalena Sansovini; Laura Gerard; Emmanuel Deshayes; Angelina Filice; Ilya Folitar
errShare
errSave
European guideline for imaging of primary paediatric and adult osteosarcoma and Ewing sarcoma: systematic review and joint statement by the FOSTER consortium, Euro Ewing Consortium, European Society of Paediatric Radiology, and the European Association of Nuclear Medicine
errLancet Oncology
IF35.9
err2026-06-29
err0
PREAI
errLaura M E Adriaansen; Johannes H M Merks; Elvira C van Dalen; Kim F Andersen; Sebastian D Asaftei; Daniel Bernabeu; Kjetil Boye; Anna Campello; Michael Capra; Sílvia Costa Dias; Raquel Dávila Fajardo; Miroslaw Dziuk; Roelof van Ewijk; Nathalie Gaspar; Craig Gerrand; Ken Herrmann; Vanina Isnardi; Nina Jehanno; Thekla von Kalle; Angel M Lancharro Zapata
errShare
errSave
Reply to Armando Stabile, Giorgio Gandaglia, Arturo Chiti, and Francesco Montorsi’s Letter to the Editor re: Ken Herrmann, Jochen Walz, Steven MacLennan, et al. SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.08.005
errEuropean Urology
IF25.2
err2026-01-29
err0
PREAI
errKen Herrmann; Louise Emmett
errShare
errSave
Clinical Impact of Changes in Tumor Uptake and Volume on PSMA PET/CT During [177Lu]Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
errJournal of Nuclear Medicine
IF9.1
err2026-01-01
err0
PREAI
errDjaileb, Loic; Farolfi, Andrea; Rauscher, Isabel; Haghighatian, Mahan; Mercier, Alexis; Fendler, Wolfgang P.; Hadaschik, Boris; Herrmann, Ken; Solnes, Lilja B.; Rettig, Matthew; Weber, Manuel; Czernin, Johannes; Calais, Jeremie; Benz, Matthias R.; Eiber, Matthias; Gafita, Andrei
errShare
errSave
The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate Cancer
errJournal of Nuclear Medicine
IF9.1
err2026-01-01
err0
PREAI
errOrtner, Gernot; Hoderlein, Xenia; Barbato, Francesco; Beyersdorff, Dirk; Buda, Lars; Burger, Irene A.; Eiber, Matthias; Graefen, Markus; Hadaschik, Boris; Haese, Alexander; Herrmann, Ken; Maack, Lennart; Maric, Ines; Mattei, Agostino; Rauscher, Isabel; Salomon, Georg; Sauer, Markus; Schimmoller, Lars; Schlaefer, Alexander; Schlemmer, Heinz-Peter; Spohn, Simon K. B.; Umutlu, Lale; Walz, Jochen; Wurnschimmel, Christoph; Koehler, Daniel; Maurer, Tobias
errShare
errSave
The value of PSMA PET for risk stratification in prostate cancer: an update and future aspects
errSeminars in Nuclear Medicine
IF5.9
err2025-12-25
err0
errOAAI
errCaner Civan; Madeleine J. Karpinski; Kambiz Rahbar; Wolfgang P. Fendler; Ken Herrmann
errShare
errSave
Treatment response assessment according to updated PROMISE criteria
errSeminars in Nuclear Medicine
IF5.9
err2025-12-13
err0
errOAAI
errTugce Telli; Caner Civan; Ken Herrmann; Wolfgang P. Fendler
errShare
errSave
New targets of PET imaging for renal cancer
errSeminars in Nuclear Medicine
IF5.9
err2025-12-01
err0
errOAAI
errY. Katayeu; V. Grünwald; K.M. Pabst; U.U. Yesilyurt; M. Al-Nader; W.P. Fendler; B.A. Hadaschik; K. Herrmann; A.T. Küper
errShare
errSave
No More Detours: Hepatopulmonary Shunt Reduction in a Patient with Hepatocellular Carcinoma after Treatment with Bevacizumab
errLiver Cancer
IF9.1
err2025-12-01
err0
errOAAI
errJeschke, Matthias; Schutte, Julia M.; Himmen, Stephan; Herrmann, Ken; Steinberg-Vorhoff, Hannah L.; Theysohn, Jens M.; Best, Jan; Schmidt, Hartmut H. -J.; Jochheim, Leonie S.
errShare
errSave
SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization
errJOURNAL OF NUCLEAR MEDICINE
IF9.1
err2025-12-01
err0
PREAI
errRowe, Steven P.; Shuch, Brian M.; Ball, Mark W.; Bex, Axel; Javadi, Mehrbod S.; Klitzke, Alan; Goffin, Karolien; Mulders, Peter; Pandit-Taskar, Neeta; Parihar, Ashwin Singh; Viglianti, Benjamin L.; Gorin, Michael A.; Herrmann, Ken
errShare
errSave
Navigating the Scoring Systems and Interpretation Frameworks of Prostate-specific Membrane Antigen PET
errRADIOLOGY
IF15.2
err2025-12-01
err1
PREAI
errWoo, Sungmin; Masci, Benedetta; Rowe, Steven P.; Caruso, Damiano; Laghi, Andrea; Burger, Irene A.; Fanti, Stefano; Herrmann, Ken; Eiber, Matthias; Loeb, Stacy; Vargas, Hebert Alberto
errShare
errSave
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024
errEuropean Journal of Cancer
IF7.1
err2025-11-21
err0
PREAI
errUrsula M. Vogl; Sara Merler; Antonio Angrisani; Fabio Turco; Ian D. Davis; Jason A. Efstathiou; Karim Fizazi; Nicholas D. James; Neal Shore; Eric J. Small; Matthew R. Smith; Christopher J. Sweeney; Bertrand Tombal; Thomas Zilli; Ken Herrmann; Aurelius Omlin; Silke Gillessen
errShare
errSave
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 68Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management
errEuropean Journal of Nuclear Medicine and Molecular Imaging
IF7.6
err2025-11-15
err0
errOAAI
errFrederik L. Giesel; Stefan A. Koerber; Boris Hadaschik; Selina Kiefer; Sarah Schwarzenboeck; Kambiz Rahbar; Thorsten Derlin; Christoph A. Grott; Matthias Heck; Cordula Jilg; Philipp T. Meyer; Juri Ruf; Karl Schmidt; Joerg Kotzerke; Christian la Fougère; Gerald Reischl; Irene Virgolini; Ken Herrmann; Irene A. Burger; Theo Lorenzini; Martin Werner; Albrecht Stenzinger; Kristina Schwamborn; Jan Philipp Radtke; Markus Hohenfellner; Juergen Debus; Wolfgang A. Weber; Uwe Haberkorn; Klaus Kopka; Matthias Eiber
errShare
errSave
Theranostics in surgical oncology
errEuropean Journal of Surgical Oncology
IF2.9
err2025-11-13
err0
errOAAI
errS. Stättner; Kjetil Soreide; Julie Hallet; Chiara Maria Grana; Stefano Partelli; Ken Herrmann; Andreas Brandl
errShare
errSave
Thyroid Hormone Withdrawal Yields Higher 131I Absorbed Dose to Metastases Than rhTSH Stimulation in Differentiated Thyroid Cancer: Evidence from a Large 124I PET/CT Dosimetry Cohort
errJOURNAL OF NUCLEAR MEDICINE
IF9.1
err2025-11-01
err0
PREAI
errCiuciulkaite, Leva; Zuccotti, Giulia A.; Jallo, Cherbel; Hautzel, Hubertus; Brandenburg, Tim; Costa, Pedro F.; Kueper, Alina T.; Himmen, Stephan M.; Goerges, Rainer; Bockisch, Andreas; Herrmann, Ken; Jentzen, Walter; Kersting, David; Fendler, Wolfgang P.
errShare
errSave
Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort: Time to treat more aggressively?
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
errOAAI
errOster, Christoph; Reineck, Pia; Schmidt, Teresa; Grieger, Jana; Sharma, Sandeep; Feldheim, Jonas; Kizina, Kathrin; Cappello, Giorgio; Jekel, Leon; Pabst, Kim M.; Ahmadipour, Yahya; Karadachi, Hanah; Rauschenbach, Laurel; Lazaridis, Lazaros; Guberina, Nika; Pottgen, Christoph; Blau, Tobias; Keyvani, Kathy; Scheffler, Bjorn; Herrmann, Ken; Kleinschnitz, Christoph; Sure, Ulrich; Stuschke, Martin; Glas, Martin; Kebir, Sied
errShare
errSave
PSMA PET/CT Reporting: Real-Life Inconsistencies, Heterogeneity, and Underutilization of Scoring Systems and Interpretation Frameworks
errRADIOLOGY
IF15.2
err2025-10-01
err0
PREAI
errVargas, Hebert Alberto; Fanti, Stefano; Herrmann, Ken; Eiber, Mathias; Rowe, Steven P.; Rivera, Adrian; Pitsoulakis, Evangelia; Becker, Anton; Woo, Sungmin; Loeb, Stacy
errShare
errSave
DISTRIBUTION AND PROGNOSTIC SIGNIFICANCE OF MYELOTOXICITY IN NEWLY DIAGNOSED GLIOBLASTOMA IN A REAL-LIFE COHORT: TIME TO TREAT MORE AGGRESSIVELY?
errNEURO-ONCOLOGY
IF13.4
err2025-10-01
err0
errOAAI
errOster, C.; Reineck, P.; Schmidt, T.; Grieger, J.; Sharma, S.; Feldheim, J.; Kizina, K.; Cappello, G.; Pabst, K.; Ahmadipour, Y.; Karadachi, H.; Rauschenbach, L.; Lazaridis, L.; Guberina, N.; Blau, T.; Pottgen, C.; Keyvani, K.; Scheffler, B.; Herrmann, K.; Kleinschnitz, C.; Sure, U.; Stuschke, M.; Glas, M.; Kebir, S.
errShare
errSave
The molecular blueprint of targeted radionuclide therapy
errNature Reviews Clinical Oncology
IF82.2
err2025-09-09
err0
PREAI
errIrina Primac; Kevin Tabury; Alpaslan Tasdogan; Sarah Baatout; Ken Herrmann
errShare
errSave
Prognostic Parameters and Detection of Cardiac Amyloidosis with Hybrid 18F-Florbetaben-PET/MRI: An exploratory observational Study
errJournal of Nuclear Cardiology
IF2.7
err2025-08-28
err0
PREAI
errDavid Kersting; Lukas Kessler; Wibke Tonscheidt; Kai Nassenstein; Stephan Settelmeier; Alexander Carpinteiro; Tim Hagenacker; Lale Umutlu; Christoph Kleinschnitz; Simon Wernhart; Lars Michel; Michal K. Chodyla; Benedikt M. Schaarschmidt; Thomas W. Schlosser; Wolfgang Fendler; Francesco Barbato; Maria Papathanasiou; Christoph Rischpler; Ken Herrmann; Tienush Rassaf
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
D
Dirk Schadendorf
H-index: 182 · Papers: 2.4K
M
Michael Weller
H-index: 175 · Papers: 2.8K
J
Johann S. de Bono
H-index: 160 · Papers: 2.5K
M
Markus Schwaiger
H-index: 151 · Papers: 1.7K
B
Bruce R. Rosen
H-index: 147 · Papers: 742
View more